Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Accounts Payable
{IF BankInsurance_zone 1}
$17,072 Mil (As of )Jun. 2016)
{IF AP_Q_zone 1}{ELSE} {/IF}

GlaxoSmithKline PLCs quarterly accounts payable increased from Dec. 2015 ($15,777 Mil) to Mar. 2016 ($15,777 Mil) and increased from Mar. 2016 ($16,434 Mil) to Jun. 2016 ($17,072 Mil)

GlaxoSmithKline PLCs quarterly accounts payable increased from Dec. 2012 ($15,231 Mil) to Dec. 2013 ($15,231 Mil) but then declined from Dec. 2013 ($15,715 Mil) to Dec. 2014 ($13,529 Mil)


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data


GlaxoSmithKline PLC Annual Data

Accts Payable 7,2619,81110,18613,34912,37914,04415,23115,71513,52915,777
{IF COMPANY->report_frequency 3M}

{COMPANY->company} Quarterly Data


{COMPANY->company} Semi-Annual Data

Accts Payable 14,40013,81414,37313,52916,87315,54815,50815,77716,43417,072

Accounts Payable does not apply to insurance companies.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)